查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371931

全球肉毒桿菌市场，预测到 2030 年：按产品类型、性别、年龄层、用途、最终用户和地区进行全球分析

Botox Market Forecasts to 2030 - Global Analysis By Product Type (Botulinum Toxin B, Botulinum Toxin A and Other Product Types), Gender (Male and Female), Age Group, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球 Botox 市场规模为 72.6 亿美元，预计到 2030 年将达到 176.3 亿美元，预测期内年复合成长率为 13.5%。

肉毒桿菌产生的神经毒性蛋白质称为肉毒桿菌或肉毒桿菌毒素。它在医学和美容上都用于暂时麻痹或放鬆肌肉。它也用于治疗多汗症、慢性头痛、肌肉痉挛和运动异常等疾病。肉毒桿菌由合格的医疗专业人员给药，谨慎给药对于防止不良反应非常重要。

根据美国整形外科医生协会的报告，2020 年肉毒桿菌手术减少了近 13%。

肉毒桿菌注射的需求增加

肉毒桿菌注射还有许多其他好处，主要是改善外观。例如，肉毒桿菌注射经常用于放鬆颞颚关节(TMJ) 的肌肉和其他类型的肌肉疼痛。此外，包括偏头痛在内的慢性健康问题可以透过注射肉毒桿菌来治疗，它可以透过阻断肌肉神经的活动来减少肌肉的过度使用。因此，肉毒桿菌注射可以帮助那些腋下出汗过多、泌尿道问题和膀胱过动症的人。

成本高

对许多人来说，Botox（肉毒桿菌）的高成本可能是一个主要障碍。费用可能会阻碍获得治疗，特别是对于那些没有足够经济能力或健康保险的人来说。此外，这种经济障碍可能会阻止人们利用毒素的药用和美容效果，从而降低他们的生活品质并降低他们的自尊。由于Botox治疗是连续的，往往需要在很长一段时间内进行多次治疗，这增加了成本负担。

非侵入性手术需求增加

40岁以上的人倾向于重视自己的外表并希望看起来更年轻。因此，特别是在已开发国家，女性对美学特征的兴趣预计将增加，对非侵入性手术的需求将加速。此外，肉毒桿菌毒素也用于治疗多种与老化相关的问题，包括鱼尾纹、眉间纹和额头皱纹。因此，40岁以上的人更容易出现这些老化症状。因此，肉毒桿菌手术在40岁至54岁之间的人群中越来越受欢迎，推动了市场的成长。

副作用

肉毒桿菌治疗因其低风险和副作用而受到高度讚扬，通常在 24 至 48 小时内消失。此外，对某些人来说，副作用可能会持续数週。例如噁心、上眼睑下垂、肩膀僵硬和头痛。因此，经常会发生过敏反应。因此，服用抗生素的人在接受肉毒桿菌治疗前应格外小心。

COVID-19 的影响

为阻止病毒传播而采取的限制和封锁措施导致许多皮肤科和美容诊所暂时关闭，限制了肉毒桿菌治疗的获得。由于整容手术等非必要医疗程序被推迟或取消，对肉毒桿菌注射的需求有所下降。而且，由于疫情引发的经济危机，人们面临经济困难，对择期整容花钱持谨慎态度。因此，总体而言，COVID-19 的爆发对 Botox 市场产生了重大影响，导致这些手术的需求和销售下降。

皮肤科诊所预计在预测期内将是最大的

据估计，皮肤科诊所所占份额最大。肉毒桿菌毒素经常在皮肤科职场给药，特别是在美容方面使用时。此外，这些诊所专门诊断和治疗各种皮肤病，并提供肉毒桿菌注射，这是消除脸部皱纹和细纹的首选非手术方法。皮肤科医师有能力评估患者的需求、选择适当的给药并适当地进行注射。此外，皮肤科诊所提供可控且卫生的氛围，这就是为什么寻求美容改善的顾客经常光顾的原因。

预计治疗领域在预测期内将经历最高的年复合成长率。

预计治疗领域在预测期内将出现最高的年复合成长率。这是因为使用肉毒桿菌进行各种治疗和预防治疗，包括持续性偏头痛、膀胱过动症和多汗症。此外，对许多肉毒桿菌毒素的作用机制和摩尔行为的了解的提高扩大了它们的治疗潜力。多汗症和反覆头痛只是可以用肉毒桿菌治疗的众多疾病中的两种。因此，这些方面正在推动市场成长。

比最大的地区

由于可支配所得的增加、美容肉毒桿菌程序的技术进步以及最先进的手术和治疗设施，北美在估计期间占据了最大的市场占有率。进一步促进该地区收益成长的是整容手术的需求不断增长、各种肉毒桿菌治疗的核准加快和检验。

复合年复合成长率最高的地区

由于增加了对推出新产品的研发项目的投资，预计欧洲在预测期内将实现盈利增长。例如，根据国际美容整形外科外科协会 (ISAPS)（2021 年）的数据，西班牙进行了 208,764 例非手术整容手术，其中包括 75,348 例肉毒桿菌治疗。此外，英国肉毒桿菌毒素市场在欧洲地区成长最快，而德国肉毒桿菌素市场占有最大的市场占有率。

免费客製化服务

订阅此报告的客户有权获得以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究来源
    • 主要研究来源
    • 二次研究来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球肉毒桿菌市场：依产品类型

  • 肉毒桿菌B
  • A型肉毒桿菌毒素
    • 运动障碍
    • 肉毒桿菌
    • 索敏
  • 其他产品类型

第6章全球肉毒桿菌市场：依性别

  • 男性
  • 女士

第7章全球肉毒桿菌市场：依年龄组

  • 13-19岁
  • 20-29岁
  • 30-39岁
  • 40-54岁
  • 55岁以上

第8章全球肉毒桿菌市场：依用途

  • 疗法
    • 膀胱过动症
    • 慢性偏头痛
    • 痉挛
    • 颈部肌张力障碍
    • 其他治疗方法
  • 美学
    • 眉毛之间的线
    • 鱼尾纹
    • 额头线
    • 其他美学
  • 其他用途

第9章全球肉毒桿菌市场：依最终用户分类

  • 水疗/美容中心
  • 医院
  • 皮肤科诊所
  • 其他最终用户

第10章全球肉毒桿菌市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第11章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第12章公司简介

  • WorldMeds LLC.
  • Syneron Candela
  • Solta Medical.
  • AbbVie
  • Allergan Inc.
  • Eisai Co., Ltd.
  • Evolus, Inc.
  • Galderma SA
  • Hugel, Inc
  • Ipsen Group
  • Lanzhou Institute of Biological Products Co. Ltd.
  • Lumenis
  • Medy Tox Inc.
  • Merz Pharma.
  • Pfizer Inc.
  • Revance Therapeutics Inc.
  • Solta Medical.
Product Code: SMRC23988

According to Stratistics MRC, the Global Botox Market is accounted for $7.26 billion in 2023 and is expected to reach $17.63 billion by 2030 growing at a CAGR of 13.5% during the forecast period. A neurotoxic protein generated from the bacteria Clostridium botulinum is known as botox or botulinum toxin. It is used both medically and cosmetically to temporarily paralyze or relax muscles. It is also used to treat medical diseases such as hyperhidrosis, chronic headaches, muscle spasms, and movement abnormalities. Botox is administered by qualified medical personnel to prevent negative consequences, careful administration is crucial.

According to the America Society of Plastic Surgeon report, nearly 13% dip were observed in botulinum toxin procedures in 2020.

Market Dynamics:

Driver:

Rising demand in Botox injections

Botox injections have numerous other benefits, primarily enhancing physical appearance. For instance, Botox injections are frequently used to help people with temporomandibular joint (TMJ) or other types of muscle pain relax their muscles. Additionally, chronic health issues, including migraines, are treated with botox injections, it can reduce the excessive use of the muscles by blocking the activity of the muscles' nerves. Hence, botox injections can help those who experience excessive underarm sweating, urinary tract disorders, or an overactive bladder.

Restraint:

High Costs

For many people, the high expense of (botulinum toxin) Botox, might be a substantial barrier. Access to the treatment may be hampered by the cost, especially for those without sufficient financial means or health insurance. Furthermore, this financial barrier may hinder people from taking advantage of the toxin's medicinal or aesthetic effects, which may lower their quality of life or lower their self-esteem. Thus, the cost burden is made higher by the ongoing nature of botox treatments, which often call for several sessions over time.

Opportunity:

Increase in demand for non-invasive surgeries

People over the age of 40 tend to focus on their physical appearance and want to look young. Thus, it is projected that increasing female attention to aesthetic traits, particularly in developed nations, will accelerate the expansion of the demand for non-invasive surgeries. Additionally, botulinum toxin is utilized to treat a variety of aging-related problems, including crow's feet, glabellar lines, forehead lines, and others. People over 40 are therefore more likely to experience these indicators of aging. Therefore, botulinum toxin operations are becoming increasingly popular among people between the ages of 40 and 54, which are boosting market growth.

Threat:

Side Effects

Botox procedures are well regarded for having fewer risks and few side effects that typically go away within 24-48 hours. Moreover, some people could experience adverse effects that can continue for weeks. Examples of these include nausea, droopy eyes, a stiff neck, headaches, and more. Therefore, allergic reactions have often occurred; as a result, individuals taking antibiotics should take extra care before receiving botox therapy.

COVID-19 Impact

The limitations and lockdown measures put in place to stop the virus's spread led to the temporary closure of numerous dermatological and beauty clinics, which restricted access to botox treatments. Botox injection demand decreased as a result of non-essential medical procedures, such as aesthetic procedures, being delayed or stopped. Additionally, the economic crisis brought on by the epidemic has caused people to face financial difficulties, which have pushed them to be more careful about spending money on elective cosmetic surgeries. Therefore, in overall, the COVID-19 pandemic has drastically impacted the market for Botox, leading to a decline in demand and sales for these procedures.

The dermatology clinics segment is expected to be the largest during the forecast period

The dermatology clinics segment is estimated to hold the largest share. Botulinum toxin is frequently administered in dermatology workplaces, especially when used cosmetically. Additionally, these clinics specialize in the diagnosis and treatment of various skin diseases and provide botulinum toxin injections, a well-liked non-surgical method for eradicating wrinkles and small lines on the face. Dermatologists have the skills to evaluate patients' needs, choose the right dosage, and properly administer injections because they are licensed medical professionals. Furthermore, a controlled and hygienic atmosphere is offered by dermatology clinics, which frequently draw clients looking for cosmetic improvements.

The therapeutics segment is expected to have the highest CAGR during the forecast period

The therapeutics segment is anticipated to have highest CAGR during the forecast period, due to a variety of therapeutic and preventive treatments, including those for persistent migraines, overactive bladders, and hyperhidrosis, are carried out using botox procedures. Additionally, enhanced knowledge of the many mechanisms of action and molar behaviour of botulinum toxin has expanded its therapeutic potential. Hyperhidrosis and recurrent headaches are only two of the many disorders that can be treated with botox. Therefore, these aspects drive the market's growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the rising disposable income, technological advancements in aesthetic botox procedures, and state-of-the-art facilities for surgery and treatment. Additionally, contributing to revenue growth in the area is the rising demand for cosmetic procedures, quick approvals, and verification of various botox treatments.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period, owing to the increased investment in R&D projects to launch new products is in the European region. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) (2021), 208,764 nonsurgical cosmetic procedures, including 75,348 botulinum toxin treatments, were performed in Spain. Additionally, the UK botulinum toxin market had the quickest rate of growth in the European region, while the German botulinum toxin market held the greatest market share.

Key players in the market:

Some of the key players in the Botox Market include: WorldMeds LLC., Syneron Candela, Solta Medical, AbbVie, Allergan Inc., Eisai Co., Ltd., Evolus, Inc.,Galderma S.A., Hugel, Inc, Ipsen Group, Lanzhou Institute of Biological Products Co. Ltd., Lumenis, Medy Tox Inc., Merz Pharma., Pfizer Inc., Revance Therapeutics Inc. and Solta Medical.

Key Developments:

In October 2022, Galderma and National Breast Cancer Foundation Inc. (NBCF) kept on their collaboration. Breast cancer survivors who had Restylane, Dysport (abobotulinumtoxinA), and/or Sculptra during Breast Cancer Awareness Month were profiled in a promotion on Galderma's social media channels.

In August 2022, the collaboration between Medytox and Bloomage Biotechnology has ended. According to Bloomage Biotechnology, since the joint venture agreement was signed, Medytox has never offered goods made by Medybloom China BTX for sale.

In July 2022, Fastox Pharma debuted the long-lasting botulinum toxin, known as LAST technology, during the "Toxins 2022 International Conference." Fastox discovered that the commencement of action of botulinum toxin type A (BoNT/A) should be accelerated by the addition of fast-acting myorelaxant drugs.

Product Types Covered:

  • Botulinum Toxin B
  • Botulinum Toxin A
  • Other Product Types

Genders Covered:

  • Male
  • Female

Age Groups Covered:

  • 13-19
  • 20-29
  • 30-39
  • 40-54
  • 55 and above

Applications Covered:

  • Therapeutics
  • Aesthetics
  • Other Applications

End Users Covered:

  • Spas and Cosmetic Centers
  • Hospitals
  • Dermatology Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Botox Market, By Product Type

  • 5.1 Introduction
  • 5.2 Botulinum Toxin B
  • 5.3 Botulinum Toxin A
    • 5.3.1 Dysport
    • 5.3.2 Botox
    • 5.3.3 Xeomin
  • 5.4 Other Product Types

6 Global Botox Market, By Gender

  • 6.1 Introduction
  • 6.2 Male
  • 6.3 Female

7 Global Botox Market, By Age Group

  • 7.1 Introduction
  • 7.2 13-19
  • 7.3 20-29
  • 7.4 30-39
  • 7.5 40-54
  • 7.6 55 and above

8 Global Botox Market, By Application

  • 8.1 Introduction
  • 8.2 Therapeutics
    • 8.2.1 Overactive Bladder
    • 8.2.2 Chronic Migraine
    • 8.2.3 Spasticity
    • 8.2.4 Cervical Dystonia
    • 8.2.5 Other Therapeutics
  • 8.3 Aesthetics
    • 8.3.1 Glabellar Lines
    • 8.3.2 Crow's Feet
    • 8.3.3 Forehead Lines
    • 8.3.4 Other Aesthetics
  • 8.4 Other Applications

9 Global Botox Market, By End User

  • 9.1 Introduction
  • 9.2 Spas and Cosmetic Centers
  • 9.3 Hospitals
  • 9.4 Dermatology Clinics
  • 9.5 Other End Users

10 Global Botox Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 WorldMeds LLC.
  • 12.2 Syneron Candela
  • 12.3 Solta Medical.
  • 12.4 AbbVie
  • 12.5 Allergan Inc.
  • 12.6 Eisai Co., Ltd.
  • 12.7 Evolus, Inc.
  • 12.8 Galderma S.A.
  • 12.9 Hugel, Inc
  • 12.10 Ipsen Group
  • 12.11 Lanzhou Institute of Biological Products Co. Ltd.
  • 12.12 Lumenis
  • 12.13 Medy Tox Inc.
  • 12.14 Merz Pharma.
  • 12.15 Pfizer Inc.
  • 12.16 Revance Therapeutics Inc.
  • 12.17 Solta Medical.

List of Tables

  • Table 1 Global Botox Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Botox Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Botox Market Outlook, By Botulinum Toxin B (2021-2030) ($MN)
  • Table 4 Global Botox Market Outlook, By Botulinum Toxin A (2021-2030) ($MN)
  • Table 5 Global Botox Market Outlook, By Dysport (2021-2030) ($MN)
  • Table 6 Global Botox Market Outlook, By Botox (2021-2030) ($MN)
  • Table 7 Global Botox Market Outlook, By Xeomin (2021-2030) ($MN)
  • Table 8 Global Botox Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 9 Global Botox Market Outlook, By Gender (2021-2030) ($MN)
  • Table 10 Global Botox Market Outlook, By Male (2021-2030) ($MN)
  • Table 11 Global Botox Market Outlook, By Female (2021-2030) ($MN)
  • Table 12 Global Botox Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 13 Global Botox Market Outlook, By 13-19 (2021-2030) ($MN)
  • Table 14 Global Botox Market Outlook, By 20-29 (2021-2030) ($MN)
  • Table 15 Global Botox Market Outlook, By 30-39 (2021-2030) ($MN)
  • Table 16 Global Botox Market Outlook, By 40-54 (2021-2030) ($MN)
  • Table 17 Global Botox Market Outlook, By 55 and above (2021-2030) ($MN)
  • Table 18 Global Botox Market Outlook, By Application (2021-2030) ($MN)
  • Table 19 Global Botox Market Outlook, By Therapeutics (2021-2030) ($MN)
  • Table 20 Global Botox Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 21 Global Botox Market Outlook, By Chronic Migraine (2021-2030) ($MN)
  • Table 22 Global Botox Market Outlook, By Spasticity (2021-2030) ($MN)
  • Table 23 Global Botox Market Outlook, By Cervical Dystonia (2021-2030) ($MN)
  • Table 24 Global Botox Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 25 Global Botox Market Outlook, By Aesthetics (2021-2030) ($MN)
  • Table 26 Global Botox Market Outlook, By Glabellar Lines (2021-2030) ($MN)
  • Table 27 Global Botox Market Outlook, By Crow's Feet (2021-2030) ($MN)
  • Table 28 Global Botox Market Outlook, By Forehead Lines (2021-2030) ($MN)
  • Table 29 Global Botox Market Outlook, By Other Aesthetics (2021-2030) ($MN)
  • Table 30 Global Botox Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 31 Global Botox Market Outlook, By End User (2021-2030) ($MN)
  • Table 32 Global Botox Market Outlook, By Spas and Cosmetic Centers (2021-2030) ($MN)
  • Table 33 Global Botox Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 34 Global Botox Market Outlook, By Dermatology Clinics (2021-2030) ($MN)
  • Table 35 Global Botox Market Outlook, By Other End Users (2021-2030) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.